Does ATORVASTATIN Cause Product solubility abnormal? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product solubility abnormal have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.
11
Reports of Product solubility abnormal with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product solubility abnormal From ATORVASTATIN?
Of the 11 reports.
Is Product solubility abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Product solubility abnormal?
BUPRENORPHINE (498)
BUPRENORPHINE\NALOXONE (274)
POLYETHYLENE GLYCOL 3350 (220)
CHOLESTYRAMINE (193)
PATIROMER (107)
LEVOTHYROXINE (100)
SOMATROPIN (98)
EXENATIDE (97)
ESTRADIOL (94)
NITROGLYCERIN (81)
Which ATORVASTATIN Alternatives Have Lower Product solubility abnormal Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM